Heart failure & cardiomyopathies

Implementation of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction (OpTIMa-HF Registry)

ESC Heart FailPublished observational, cross-sectional, multicentre, real-life Italian registry

Authors' conclusion

The OPTIMA-HF registry reported that HFrEF fundamental drugs are prescribed in most Italian patients; however, <50% of patients receive optimal combination therapy, and still not a satisfying number of patients receive target doses. Strategies to improve implementation of guideline-directed medical therapy are needed to improve HF prognosis.

Study context

Population
Chronic heart failure (HF) outpatients with HF with reduced ejection fraction (HFrEF), consecutive patients seen between January and October 2022 (T0 phase)HF patients enrolled by 29 centres, of which 1390 (65.9%) had HFrEF · HFrEF 1,390
Participants
2,110 outpatients
Outcome
Characteristics of HFrEF patients
Methodological detailsT0 phase-retrospective data collection, conducted in HF outpatients' clinics of Italian hospitals and community HF outpatients' services
  • T0 phase-retrospective data collection
  • Conducted in HF outpatients' clinics of Italian hospitals and community HF outpatients' services

Main finding

As reported in the abstract

Age

69.5 ± 11.9 years

Males

76.2%

Time since HF diagnosis

4.1 years

Median ejection fraction (EF)

33%

Observational data: associations, not effects.

Further findings

Prescription rates among HFrEF patients

Renin-angiotensin-aldosterone system inhibitor (RAASi)/angiotensin receptor neprilysin inhibitor (ARNI)
89.1%
ARNI
72%
RAASi
17.1%
Beta-blockers
95.1%
Mineralocorticoid receptor antagonists (MRA)
75.8%
SGLT2i
63.2%

Untreated patients without contraindications

A non-negligible number of patients with no contraindications were not treated with each specific drug

Patients taking all four drug classes

All four drug classes
46.9%

Doses

Still low number of patients on RAASi/ARNI and beta-blockers treated with a dose ≥50% of target doses

Original publication

Implementation of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction (OpTIMa-HF Registry). ESC Heart Fail. Published 5 February 2025. doi:10.1002/ehf2.15172

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.